# NCT04564703 (NCT04564703)

> Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04564703
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Stichting European Myeloma Network
- Conditions: Multiple Myeloma
- Interventions: Iberdomide
- Enrollment: 160
- Primary outcome: Efficacy: rate of improvement in response with iberdomide maintenance after autologous stem cell transplantation (ASCT)
- Primary outcome: Rate of dose reductions/discontinuations with iberdomide maintenance after ASCT

## Commentary we found

- YouTube: 9
- X threads: 6
- Podcasts: 5

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=nct04564703

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04564703", "email": "<work email>"}; the inbox owner confirms by the emailed link.